Literature DB >> 11495918

Activity-dependent development of P2X7 current and Ca2+ entry in rabbit osteoclasts.

L N Naemsch1, S J Dixon, S M Sims.   

Abstract

Bone remodeling is regulated by local factors and modulated by mechanical stimuli. Mechanical stimulation can cause release of ATP, an agent that stimulates osteoclastic resorption at low concentrations and inhibits at high concentrations. We examined whether osteoclasts express P2X(7) receptors, which are activated by high concentrations of ATP and can behave as ion channels or cause the formation of membrane pores. Rabbit osteoclasts were studied using patch clamp techniques. Successive or prolonged applications of 2'- & 3'-O-(4-benzoylbenzoyl)-ATP (BzATP, a relatively potent P2X(7) agonist) or high concentrations of ATP caused the development of a slowly deactivating inward current. The underlying channel was permeable only to small cations, ruling out pore formation. Divalent cations reduced current magnitude, consistent with the presence of P2X(7) receptors, a finding confirmed in rat osteoclasts by immunocytochemistry. Successive applications of BzATP also elicited [Ca(2+)](i) elevations that required extracellular Ca(2+). The BzATP-induced current and the rise of [Ca(2+)](i) were temporally associated, and both were inhibited by PPADS, a P2X(7) antagonist. This study demonstrates that high concentrations of ATP activate P2X(7) receptors and provides the first functional evidence for an extracellular ligand-gated Ca(2+) influx pathway in osteoclasts. ATP released in response to mechanical stimuli may act through P2X(7) receptors to inhibit osteoclastic resorption.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11495918     DOI: 10.1074/jbc.M105881200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Single-nucleotide polymorphisms in the P2X7 receptor gene are associated with post-menopausal bone loss and vertebral fractures.

Authors:  Niklas R Jørgensen; Lise B Husted; Kristen K Skarratt; Leanne Stokes; Charlotte L Tofteng; Torben Kvist; Jens-Erik B Jensen; Pia Eiken; Kim Brixen; Stephen Fuller; Rory Clifton-Bligh; Alison Gartland; Peter Schwarz; Bente L Langdahl; James S Wiley
Journal:  Eur J Hum Genet       Date:  2012-01-25       Impact factor: 4.246

Review 2.  Pharmacology of P2X channels.

Authors:  Joel R Gever; Debra A Cockayne; Michael P Dillon; Geoffrey Burnstock; Anthony P D W Ford
Journal:  Pflugers Arch       Date:  2006-04-29       Impact factor: 3.657

3.  Invited Lectures : Overviews Purinergic signalling: past, present and future.

Authors: 
Journal:  Purinergic Signal       Date:  2006-05-15       Impact factor: 3.765

Review 4.  Purinergic signalling in the musculoskeletal system.

Authors:  Geoffrey Burnstock; Timothy R Arnett; Isabel R Orriss
Journal:  Purinergic Signal       Date:  2013-08-14       Impact factor: 3.765

5.  Osteopontin signals through calcium and nuclear factor of activated T cells (NFAT) in osteoclasts: a novel RGD-dependent pathway promoting cell survival.

Authors:  Natsuko Tanabe; Benjamin D Wheal; Jiyun Kwon; Hong H Chen; Ryan P P Shugg; Stephen M Sims; Harvey A Goldberg; S Jeffrey Dixon
Journal:  J Biol Chem       Date:  2011-09-22       Impact factor: 5.157

6.  Functional polymorphisms in the P2X7 receptor gene are associated with osteoporosis.

Authors:  L B Husted; T Harsløf; L Stenkjær; M Carstens; N R Jørgensen; B L Langdahl
Journal:  Osteoporos Int       Date:  2012-06-16       Impact factor: 4.507

7.  P2X7 receptor inhibition increases CNTF in the subventricular zone, but not neurogenesis or neuroprotection after stroke in adult mice.

Authors:  Seong Su Kang; Matthew Phillip Keasey; Theo Hagg
Journal:  Transl Stroke Res       Date:  2013-10       Impact factor: 6.829

8.  Secretion of L-glutamate from osteoclasts through transcytosis.

Authors:  Riyo Morimoto; Shunsuke Uehara; Shouki Yatsushiro; Narinobu Juge; Zhaolin Hua; Shigenori Senoh; Noriko Echigo; Mitsuko Hayashi; Toshihide Mizoguchi; Tadashi Ninomiya; Nobuyuki Udagawa; Hiroshi Omote; Akitsugu Yamamoto; Robert H Edwards; Yoshinori Moriyama
Journal:  EMBO J       Date:  2006-09-07       Impact factor: 11.598

9.  Atypical P2X receptor pharmacology in two human osteoblast-like cell lines.

Authors:  S M Alqallaf; B A J Evans; E J Kidd
Journal:  Br J Pharmacol       Date:  2009-02-18       Impact factor: 8.739

10.  Expression, signaling, and function of P2X7 receptors in bone.

Authors:  Matthew W Grol; Nattapon Panupinthu; Jasminka Korcok; Stephen M Sims; S Jeffrey Dixon
Journal:  Purinergic Signal       Date:  2009-02-18       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.